LUX Infusion Acquires Infuse IQ, Expanding Its National Ambulatory Infusion Footprint

LUX Infusion, a clinician-led infusion services company, has announced the acquisition of Infuse IQ, an independent infusion therapy provider based in Wyoming, for an undisclosed amount. The transaction, which was made public on August 6, 2026, is expected to enhance LUX Infusion's omnichannel infusion capabilities and expand its network across the United States, allowing for improved access to infusion services for patients and referring providers.

Infuse IQ has established a strong reputation in the infusion therapy sector, delivering personalized infusion and injection treatments across a variety of medical specialties. With six clinic locations and a highly skilled clinical team, Infuse IQ's operational model aligns closely with LUX Infusion's commitment to patient-centered care. Both companies prioritize removing barriers to access and delivering high-quality infusion experiences outside of hospital settings, making this acquisition a strategic fit that promises to enhance service delivery.

The integration of Infuse IQ into LUX Infusion's platform is anticipated to provide significant benefits for patients and healthcare providers alike. Patients will gain access to a broader network of clinical expertise, facilitating faster therapy starts and enhanced support in navigating insurance and financial challenges. For referring providers, the acquisition offers a reliable partner equipped with the necessary infrastructure and data-sharing capabilities to maintain close connections with their patients throughout the treatment process.

This acquisition is part of LUX Infusion's broader strategy to build a fully integrated, nationally scaled infusion services platform through targeted growth initiatives. The company has been actively expanding its omnichannel model, which includes both home infusion and ambulatory infusion centers, to ensure that patients receive exceptional, coordinated care regardless of their treatment location. With a network that now spans from Alaska to the Southeast, LUX Infusion is well-positioned to meet the growing demand for infusion services across the country.

The acquisition of Infuse IQ underscores the ongoing momentum in the infusion therapy sector, as companies seek to enhance their service offerings and expand their reach. As the healthcare landscape continues to evolve, LUX Infusion's commitment to innovation and patient-centered care will likely play a pivotal role in shaping the future of infusion services. The integration of Infuse IQ into its operations not only strengthens LUX Infusion's market position but also reflects a broader trend towards consolidation in the healthcare sector, aimed at improving patient outcomes and operational efficiencies.